Skip to main content
OpenTrials

Clinical trial condition

Neurofibromatosis Type 2

Explore clinical trials studying Neurofibromatosis Type 2. Study availability and eligibility vary by location and protocol.

14 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Neurofibromatosis Type 2 trial results

Recruiting

Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)

NCT04374305

Conditions
Central Nervous System Neoplasms, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, +38 more
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • University of Miami Miami, Florida, United States
  • Indiana University School of Medicine Indianopolis, Indiana, United States
  • Johns Hopkins Hospital Baltimore, Maryland, United States
View Trial Details
Not Yet Recruiting

Platform Research for Innovative Medicines in NF2-SWN (PRIME-NF2)

NCT07713745

Conditions
Central Nervous System Neoplasms, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, +40 more
Locations
  • Xuanwu Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Beijing Tiantan Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Chinese PLA General Hospital Beijing, Beijing Municipality, China
  • The First Hospital of Jilin University Changchun, Jilin, China
View Trial Details
Not Yet Recruiting

Luvometinib in Combination With Serplulimab for NF2-Related Tumors

NCT07708285

Conditions
Central Nervous System Neoplasms, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, +35 more
Locations
  • Xuanwu Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Beijing Tiantan Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Chinese PLA General Hospital Beijing, Beijing Municipality, China
  • The First Hospital of Jilin University Changchun, Jilin, China
View Trial Details
Not Yet Recruiting

Selumetinib for NF2-Related Schwannomatosis

NCT07707947

Conditions
Central Nervous System Neoplasms, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, +39 more
Locations
  • Beijing Tiantan Hospital, Capital Medical University Beijing, Beijing Municipality, China
View Trial Details
Completed

Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas

NCT01767792

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Cranial Nerve Neoplasms, +26 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Children's HealthCare of Atlanta Atlanta, Georgia, United States
  • University of Chicago Chicago, Illinois, United States
View Trial Details
Completed

Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas

NCT01125046

Conditions
Acoustic Schwannoma, Adult Anaplastic Meningioma, Adult Ependymoma, +51 more
Locations
  • Northwestern University Chicago, Illinois, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Columbia University Medical Center New York, United States
  • University of Virginia Charlottesville, Virginia, United States
View Trial Details

Related conditions